Please log in to see the full text of this API!
Amprenavir
-
Synonyms:
KUX 478, UX 478, 141W94
-
ATC:
J05AE05
-
Use:
Lorem
Lorem
Lorem
-
Chemical name:
Lorem ipsum dolor sit amet, consetetur sadipscing elitr, sed diam
-
Formula:
Lorem ipsum dolor sit amet,
-
MW:505.64 g/mol
-
CAS-RN:161814-49-9
-
InChI Key:YMARZQAQMVYCKC-OEMFJLHTSA-N
-
InChI:InChI=1S/C25H35N3O6S/c1-18(2)15-28(35(31,32)22-10-8-20(26)9-11-22)16-24(29)23(14-19-6-4-3-5-7-19)27-25(30)34-21-12-13-33-17-21/h3-11,18,21,23-24,29H,12-17,26H2,1-2H3,(H,27,30)/t21-,23-,24+/m0/s1
Substances Referenced in Synthesis Path
CAS-RN |
Formula |
Chemical Name |
CAS Index Name |
251105-80-3 |
C20H27N3O5S |
N-[(2R,3S)-3-amino-2-hydroxy-4-phenylbutyl]-N-(2-methylpropyl)-4-nitrobenzenesulfonamide |
Benzenesulfonamide, N-[(2R,3S)-3-amino-2-hydroxy-4-phenylbutyl]-N-(2-methylpropyl)-4-nitro- |
160232-11-1 |
C22H31ClN2O3 |
benzyl [(2R,3S)-3-amino-2-hydroxy-4-phenylbutyl](2-methylpropyl)carbamate monohydrochloride |
Carbamic acid, [(2R,3S)-3-amino-2-hydroxy-4-phenylbutyl](2-methylpropyl)-, phenylmethyl ester, monohydrochloride |
501-53-1 |
C8H7ClO2 |
benzyl chloroformate |
Carbonochloridic acid, phenylmethyl ester |
160232-10-0 |
C27H38N2O5 |
benzyl [(2R,3S)-3-[[(1,1-dimethylethoxy)carbonyl]amino]-2-hydroxy-4-phenylbutyl](2-methylpropyl)carbamate |
Carbamic acid, [(2R,3S)-3-[[(1,1-dimethylethoxy)carbonyl]amino]-2-hydroxy-4-phenylbutyl](2-methylpropyl)-, phenylmethyl ester |
Lorem |
Lorem |
Lorem |
Lorem |
Lorem |
Lorem |
Lorem |
Lorem |
Lorem |
Lorem |
Lorem |
Lorem |
Lorem |
Lorem |
Lorem |
Lorem |
Lorem |
Lorem |
Lorem |
Lorem |
Lorem |
Lorem |
Lorem |
Lorem |
Lorem |
Lorem |
Lorem |
Lorem |
Lorem |
Lorem |
Lorem |
Lorem |
Lorem |
Lorem |
Lorem |
Lorem |
Lorem |
Lorem |
Lorem |
Lorem |
Lorem |
Lorem |
Lorem |
Lorem |
Lorem |
Lorem |
Lorem |
Lorem |
Lorem |
Lorem |
Lorem |
Lorem |
Lorem |
Lorem |
Lorem |
Lorem |
Lorem |
Lorem |
Lorem |
Lorem |
Lorem |
Lorem |
Lorem |
Lorem |
Lorem |
Lorem |
Lorem |
Lorem |
Trade Names
Country |
Trade Name |
Vendor |
Annotation |
D |
Lorem |
Lorem
|
|
F |
Lorem |
Lorem
|
|
GB |
Lorem |
Lorem
|
|
I |
Lorem |
Lorem
|
|
USA |
Lorem |
Lorem
,1999 |
|
(wfm = withdrawn from market)
Formulations
- Loremipsumdolorsitamet,consetetursadipscingelitr,
References
-
- a WO 9 999 999 (Vertex Pharm.; appl. 7.9.1993; USA-prior. 8.9.1992).
- US 9 999 999 (Vertex; 17.12.1996; appl. 7.9.1993).
- aa Brown, H.C. et al.: J. Am. Chem. Soc. (JACSAT) 108, 2049-2054 (1986).
- b WO 9 999 999 (Vertex Pharm.; appl. 18.4.1996; USA-prior. 19.4.1995; 8.9.1992).
- US 9 999 999 (Vertex; 3.3.1998; appl. 19.4.1995).
- c JP 99 999 999 (Kissei Pharm.; appl. 26.10.1995).
-
nanocrystalline formulations:
- WO 9 999 999 (Nanosystems; appl. 9.7.1998; USA-prior. 9.7.1997).
-
stable crystal polymorphs:
- WO 9 999 999 (Vertex Pharm.; appl. 16.6.1998; USA-prior. 16.6.1997).
-
novel crystal form V:
- WO 9 999 999 (Glaxo; 17.12.1998; appl. 11.6.1998; USA-prior. 13.6.1997).
-
combination with AZT:
- US 9 999 999 (Vertex; 8.7.1997; appl. 5.12.1995).
- WO 9 999 999 (Vertex Pharm.; 12.6.1997; appl. 5.12.1996; USA-prior. 5.12.1995).
-
crystallization of amprenavir:
- JP 99 999 999 (Kissei Pharm.; appl. 7.9.1995).